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INTRODUCTION

HPV FAVORS HIV ACQUISITION

PROPOSED PREVENTION STRATEGIES

It has been well documented that HIV infection is associated with HPV infection
and the progression to cervical carcinoma. Since the spread of HIV/AIDS
epidemic, HPV-related cervical carcinoma had such a high prevalence in HIVinfected individuals that it became established as an AIDS-defining illness.
Cervical cancer is the most common AIDS-related malignancy, and the sixth
most common presenting AIDS-defining illness in women.1 Additionally, HIV
infection leads to a 5-fold increase in multiple new HPV infections within 6 weeks
of seroconversion.2 Not only does HIV impact acquisition of HPV at molecular
and cellular levels, HIV and HPV viruses interact in complex ways such that each
enhances the acquisition and amplification of the other.

-Risk of acquiring HIV is doubled when infection by HPV of any genotype is
present prior to HIV exposure
-Risk of acquiring HIV is increased if infected with two or more genotypes of
HPV concurrently3
-Significantly increased HIV risk when type-specific HPV was non-persistent
-Infection with HPV genotypes covered by the 9-valent vaccine associated
with more than 2.5 times increased risk for HIV acquisition versus 2 times
increased risk with genotypes covered by the quadrivalent vaccine
-Up to 37% of HIV infections in women in sub-Saharan Africa were
attributable to infection with prevalent HPV of any genotype2

-While a direct causative relationship between HPV and HIV
acquisition has not been established, the association may be
capitalized on as a point of intervention and prevention, especially in
areas in which both HPV and HIV infections are endemic.

EPIDEMIOLOGIC IMPACT OF CO-INFECTION
-HPV infection and ICC incidence rates show highest prevalence in regions
where HIV infection is most prevalent
-85% of the world’s cervical cancer burden is in developing countries, with a
large proportion in sub-Saharan Africa where rates are as high as
34.5/100,000 women
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HPV infection prevalence in the cervix and invasive cervical cancer incidence
according to WHO HIV seroprevalence distribution in 2010.( 3)

-There is a shift in HPV genotype distribution in some countries highly
endemic for HIV in sub-Saharan Africa
-One study found that the distribution of HR HPV genotypes found in ICC
samples of 38 countries is different according to the extent of HIV infection
within those countries
-Although HPV type 16 remained the most common genotype found in ICC
in all of the countries, in countries with higher HIV seroprevalence types 16
and 45 were found relatively less frequently and type 18 more frequently4
-HIV infected women with HSIL showed a higher proportion of infection with
non-16 genotypes such as 11, 18, 33, 51, 52, 53, 58, 61, and with multiple
HPV types5

POSSIBLE MECHANISMS
-HPV is a DNA virus with a tropism
for squamous epithelium6
-HR HPV genotypes produce E6
and E7 proteins
-E7 down-regulates E-cadherin,
Potentially increasing permeability
of the genital lining to HIV2
-HPV-infected tissue has
demonstrated a reduced density
and altered morphology of
Langerhans’ cells within the lining
of the genital tract, reducing protection from HIV2
-The host immune response to HPV is mediated by T-lymphocytes
Recruitment of primary target cells for HIV to the genital mucosa to
eliminate the HPV infection
-Loss of HPV detection can happen just before detection of HIV
acquisition3
-HPV non-persistence, which is likely to be associated with a Tlymphocyte influx, was shown to be associated with HIV acquisition
when persistent infection was not2
-Women with HPV-associated cervical dysplasia have demonstrated
elevated levels of cytokine IL-Iβ, which activates a promoter region in the
HIV genome2

OTHER CONTRIBUTING FACTORS
-Similar behavioral risk factors for acquisition of HPV and HIV infections,
including lack of condom use, multiple sexual partners, and high-risk sexual
partners
-Age at infection often earlier for HPV than HIV3
-There is a need for prevention before sexual debut to have meaningful
impact, because HIV infected individuals may already harbor HPV
infection, reducing efficacy of ICC prevention through vaccination of
HIV+ individuals

-Due to the high cervical cancer
burden in these dual-endemic
areas, there is no question that a
HPV vaccination program will
have profound implications on
improving outcomes for women
in reducing incidence of
HPV-related cervical cancer.
-It should also be considered for
the potential implications in
reducing the spread of HIV and its associated morbidity and mortality.
-However, because of the variation in HPV subtypes causing high
grade cervical intraepithelial lesions and cervical carcinoma in these
locations, utilization of the currently available vaccine may not be
sufficient to significantly impact the spread of HPV, and therefore
potential spread of HIV, in susceptible populations.

CONCLUSION
An vigorous vaccine program of the multivalent vaccine currently in clinical
trials, covering HPV genotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58,4 needs to
be implemented and studied in endemic areas in order to determine the impact
that HPV prevention may have on reducing the spread of HIV in those
Populations.
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